Back

Prognostic impact of gamma-glutamyltransferase in transthyretin amyloid cardiomyopathy

12 May 2026 (08:30 - 10:30)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (6) Clinical HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Asuka Kuwahara

National Cerebral & Cardiovascular Center, Suita (Japan)

Access the full session

Session thumbnail
ePosters in myocardial disease (6)

The Event

Event poster

Heart Failure 2026

12 May 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Prognostic value of cardiac biomarkers in patients with transthyretin deposition cardiac amyloidosis.
29 June 2021
thumbnail
Congress Session
Heart failure and ATTR-CM: recognizing an underdiagnosed condition
20 May 2023
thumbnail
Congress Presentation
Increase in serum TTR levels observed with acoramidis treatment in patients with transthyretin amyloid cardiomyopathy (ATTR-CM): insights from ATTRibute-CM and its open-label extension
30 August 2024
thumbnail
Congress Presentation
Deep screening unveils hidden cardiac amyloidosis: carpal tunnel syndrome as a gateway to early transthyretin cardiac amyloidosis diagnosis
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources